Want to see AU:PIQ full AI Analyst Report?
Total Valuation
Proteomics International Laboratories Ltd. has a market cap or net worth of AU$19.00M. The enterprise value is AU$14.49M.
Market CapAU$19.00M
Enterprise ValueAU$14.49M
Share Statistics
Proteomics International Laboratories Ltd. has 165,197,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding165,197,510
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Proteomics International Laboratories Ltd.’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -78.70%.
Return on Equity (ROE)-0.62
Return on Assets (ROA)-0.55
Return on Invested Capital (ROIC)-78.70%
Return on Capital Employed (ROCE)-0.80
Revenue Per Employee5.97K
Profits Per Employee-50.40K
Employee Count161
Asset Turnover0.06
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Proteomics International Laboratories Ltd. is ―. Proteomics International Laboratories Ltd.’s PEG ratio is -0.84.
PE Ratio―
PS Ratio50.61
PB Ratio3.69
Price to Fair Value3.69
Price to FCF-7.33
Price to Operating Cash Flow-2.97
PEG Ratio-0.84
Income Statement
In the last 12 months, Proteomics International Laboratories Ltd. had revenue of 960.39K and earned -8.11M in profits. Earnings per share was -0.05.
Revenue960.39K
Gross Profit960.39K
Operating Income-10.62M
Pretax Income-8.15M
Net Income-8.11M
EBITDA-10.00M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -6.35M and capital expenditures -2.07M, giving a free cash flow of -8.41M billion.
Operating Cash Flow-6.35M
Free Cash Flow-8.41M
Free Cash Flow per Share-0.05
Dividends & Yields
Proteomics International Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-68.06%
50-Day Moving Average0.16
200-Day Moving Average0.35
Relative Strength Index (RSI)33.72
Average Volume (3m)426.90K
Important Dates
Proteomics International Laboratories Ltd. upcoming earnings date is Sep 1, 2026, TBA (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateSep 1, 2026
Ex-Dividend Date―
Financial Position
Proteomics International Laboratories Ltd. as a current ratio of 9.39, with Debt / Equity ratio of 9.15%
Current Ratio9.39
Quick Ratio9.39
Debt to Market Cap0.00
Net Debt to EBITDA1.08
Interest Coverage Ratio-252.57
Taxes
In the past 12 months, Proteomics International Laboratories Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Proteomics International Laboratories Ltd. EV to EBITDA ratio is -3.79, with an EV/FCF ratio of -5.70.
EV to Sales39.40
EV to EBITDA-3.79
EV to Free Cash Flow-5.70
EV to Operating Cash Flow-5.73
Balance Sheet
Proteomics International Laboratories Ltd. has AU$7.67M in cash and marketable securities with AU$681.45K in debt, giving a net cash position of AU$6.99M billion.
Cash & Marketable SecuritiesAU$7.67M
Total DebtAU$681.45K
Net CashAU$6.99M
Net Cash Per ShareAU$0.04
Tangible Book Value Per ShareAU$0.09
Margins
Gross margin is -1927.07%, with operating margin of -1105.67%, and net profit margin of -844.95%.
Gross Margin-1927.07%
Operating Margin-1105.67%
Pretax Margin-849.08%
Net Profit Margin-844.95%
EBITDA Margin-1040.83%
EBIT Margin-1105.67%
Analyst Forecast
The average price target for Proteomics International Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-23.71%
EPS Growth Forecast-16.02%